The TRUST Trial - CardioVascular Imaging ECHO

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 185 participants.

Also called NCT02832960

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 185 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02832960
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02832960. Randomized; quadruple masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2016-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The TRUST Trial - CardioVascular Imaging ECHO
Condition
Thyroid Dysfunction
Condition
Atherosclerosis
Condition
Heart Failure
Intervention (Drug)
Levothyroxine
Intervention (Drug)
Placebo
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)
Collaborator
University of Lausanne Hospitals (class: other)
Collaborator
University Hospital, Geneva (class: other)

Record details

Record id
cardio:ct-nct02832960
Content hash
8d502e9eb65a04154dc4ba9c12f2d5af51f1de5a9d567404f834b4258208c2c7